Skip to Main Content

You can add Maine to the growing list of states that have passed a law seeking more transparency about prescription drug pricing.

However, unlike a few states that quickly required drug makers to provide cost and pricing information about their medicines – California, Vermont, Nevada, and Oregon — Maine is taking a two-step approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • This line struck me – “passing legislation to lower drug costs should be a “top priority” for President Trump, who is expected to deliver a speech about the issue.”
    I thought the President’s objection to the last administration was ‘all talk and no action’ – the tradition continues, it would seem. (And wasn’t said speech due last week?)

Comments are closed.